Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma

SIMPLE SUMMARY: Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans. The therapeutic landscape of CSCC has change in recent years, after the approval of immune checkpoint inhibitors (ICI) in advanced CSCC. However, not all patients will respond to ICI, and those who...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Sancha, Natalia, Corchado-Cobos, Roberto, Bellido-Hernández, Lorena, Román-Curto, Concepción, Cardeñoso-Álvarez, Esther, Pérez-Losada, Jesús, Orfao, Alberto, Cañueto, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533861/
https://www.ncbi.nlm.nih.gov/pubmed/34680282
http://dx.doi.org/10.3390/cancers13205134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533861/
https://www.ncbi.nlm.nih.gov/pubmed/34680282
http://dx.doi.org/10.3390/cancers13205134

Ejemplares similares